XETRA - Delayed Quote EUR
MeVis Medical Solutions AG (M3V.DE)
25.20
0.00
(0.00%)
At close: June 2 at 5:36:15 PM GMT+2
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
16,972
16,972
17,342
18,762
16,214
Cost of Revenue
489.67
489.67
445.25
746.56
436.85
Gross Profit
16,482.33
16,482.33
16,896.75
18,015.44
15,777.15
Operating Expense
12,479.90
12,479.90
11,991.82
11,545.14
10,750.09
Operating Income
4,002.43
4,002.43
4,904.93
6,470.29
5,027.06
Net Non Operating Interest Income Expense
132.45
132.45
67.82
-3.85
150.97
Pretax Income
4,687.53
4,687.53
5,033.78
7,876.63
4,630.68
Tax Provision
126.40
126.40
114.18
87.11
85
Net Income Common Stockholders
4,560.82
4,560.82
4,919.55
7,789.05
4,545.68
Diluted NI Available to Com Stockholders
4,560.82
4,560.82
4,919.55
7,789.05
4,545.68
Basic EPS
0.00
--
0.00
4.28
2.50
Diluted EPS
0.00
--
0.00
4.28
2.50
Basic Average Shares
1,820
--
1,820
1,820
1,820
Diluted Average Shares
1,820
--
1,820
1,820
1,820
Rent Expense Supplemental
551
551
518
552
461
Total Expenses
12,969.57
12,969.57
12,437.07
12,291.71
11,186.94
Net Income from Continuing & Discontinued Operation
4,560.82
4,560.82
4,919.55
7,789.05
4,545.68
Normalized Income
4,560.82
4,560.82
4,919.55
7,789.05
5,142.52
Interest Income
152.07
152.07
110.64
0
161.79
Interest Expense
19.62
19.62
42.82
3.85
10.82
Net Interest Income
132.45
132.45
67.82
-3.85
150.97
EBIT
4,707.15
4,707.15
5,076.60
7,880.48
4,641.50
EBITDA
4,839.88
4,839.88
5,172.44
7,973.53
4,767.02
Reconciled Cost of Revenue
489.67
489.67
445.25
746.56
436.85
Reconciled Depreciation
132.74
132.74
95.84
93.05
125.51
Net Income from Continuing Operation Net Minority Interest
4,560.82
4,560.82
4,919.55
7,789.05
4,545.68
Total Unusual Items Excluding Goodwill
--
--
--
--
-608
Total Unusual Items
--
--
--
--
-608
Normalized EBITDA
4,839.88
4,839.88
5,172.44
7,973.53
5,375.02
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-11.16
9/30/2021 - 11/16/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade